Direkt zum Inhalt
Merck
  • Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor.

Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor.

Journal of medicinal chemistry (2013-10-01)
Tracey Huynh, Celine Valant, Ian T Crosby, Patrick M Sexton, Arthur Christopoulos, Ben Capuano
ZUSAMMENFASSUNG

The M4 mAChR is implicated in several CNS disorders and possesses an allosteric binding site for which ligands modulating the affinity and/or efficacy of ACh may be exploited for selective receptor targeting. We report the synthesis of a focused library of putative M4 PAMs derived from VU0152100 and VU10005. These compounds investigate the pharmacological effects of previously identified methoxy and fluoro substituents, providing useful estimates of affinity (KB), cooperativity (αβ), and direct agonist properties (τB).

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Acetylcholinchlorid, ≥99% (TLC)
Sigma-Aldrich
Acetylcholinchlorid, suitable for cell culture
Sigma-Aldrich
Acetylcholiniodid, ≥97%
Sigma-Aldrich
Acetylcholinchlorid, pkg of 150 mg (per vial)
Sigma-Aldrich
Acetylcholinbromid, ≥99%
Sigma-Aldrich
Acetylcholinchlorid, ≥99% (TLC), free-flowing, Redi-Dri